Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain
The use of siRNA-based therapies for the treatment of neurodegenerative disease requires efficient, nontoxic distribution to the affected brain parenchyma, notably the striatum and cortex. Here, we describe the synthesis and activity of a fully chemically modified siRNA that is directly conjugated t...
Saved in:
Main Authors: | Mehran Nikan (Author), Maire F Osborn (Author), Andrew H Coles (Author), Bruno MDC Godinho (Author), Lauren M Hall (Author), Reka A Haraszti (Author), Matthew R Hassler (Author), Dimas Echeverria (Author), Neil Aronin (Author), Anastasia Khvorova (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAs
by: Bruno M.D.C. Godinho, et al.
Published: (2022) -
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
by: Socheata Ly, et al.
Published: (2020) -
Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain
by: Julia F Alterman, et al.
Published: (2015) -
Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs
by: James W. Gilbert, et al.
Published: (2024) -
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
by: Chantal M. Ferguson, et al.
Published: (2020)